FeNO, or fractional exhaled nitric oxide, is a simple and effective way to measure airway inflammation—one of the key indicators in respiratory conditions such as asthma. This video introduces FeNO as a modern biomarker that provides healthcare professionals with a direct insight into what is happening inside a patient’s lungs, helping guide diagnosis and treatment decisions.

In everyday clinical practice, understanding airway inflammation can be challenging using traditional methods alone. FeNO testing offers a clear advantage by delivering a quantitative result through a fast and non-invasive procedure. By measuring the level of nitric oxide in a patient’s breath, clinicians can identify inflammation linked to asthma and related conditions with greater confidence and precision.

The video highlights how easy the FeNO test is to perform. Patients simply inhale and then exhale steadily into a handheld device, making the process quick, comfortable, and suitable for a wide range of patients, including children. The entire procedure typically takes only a few minutes and does not require blood samples or complex preparation, reinforcing its practicality in both primary care and specialist settings.

Another key message is the clinical value of FeNO in ongoing asthma management. Elevated FeNO levels indicate airway inflammation, while lower levels can reflect effective treatment. This allows healthcare providers to monitor patient response to therapy, adjust medication when necessary, and reduce the risk of exacerbations.

Overall, the video presents FeNO as a reliable, patient-friendly, and efficient diagnostic tool. By enabling real-time assessment of airway inflammation, it supports better clinical decisions and contributes to improved respiratory care outcomes.